Keywords
Patient journey map
Whole-process management
Self-management ability
Quality of life
Submitted : 2026-04-20
Accepted : 2026-05-05
Published : 2026-05-20
Abstract
Objective: To establish a full-process management model for liver cancer patients undergoing interventional therapy based on the Patient Journey Map (PJM), and to evaluate its application effect. Methods: A non-synchronous controlled trial design was adopted. 120 liver cancer patients who underwent transcatheter arterial chemoembolization (TACE) in the Department of Infection of our hospital from January 2025 to December 2025 were selected. The control group included 60 patients (1–6 months) who received routine care, while the experimental group included 60 patients (7–12 months) who received the full-process management based on the Patient Journey Map. Through semi-structured interviews, the key touchpoints and needs of patients were clarified, and the Patient Journey Map was drawn. A three-stage full-process management plan of “hospitalization period - discharge preparation period - home rehabilitation period” was constructed. The satisfaction of patients, the incidence of postoperative complications, self-management ability, quality of life, and readmission rate were compared between the two groups. Results: The satisfaction rate of patients in the experimental group (96.67%) and the total score of self-management ability (86.35 ± 5.21) and the total score of quality of life (78.56 ± 6.42) were all higher than those in the control group (81.67%, 72.48 ± 6.35, 65.32 ± 7.18), respectively; the incidence of complications (13.33%) and the 30-day readmission rate (6.67%) were lower than those in the control group (30.00%, 18.33%), and the differences were statistically significant (P < 0.05). Conclusion: The full-process management model based on the Patient Journey Map can improve the satisfaction of liver cancer patients undergoing interventional therapy, reduce the incidence of complications and readmission rate, and improve self-management ability and quality of life, and has clinical application value.
References
Primary Liver Cancer Diagnosis and Treatment Guidelines, 2024, Primary Liver Cancer Diagnosis and Treatment Guidelines (2024 Edition). Electronic Journal of Comprehensive Cancer Treatment, 10(03): 17–68.
Bray F, Laversanne M, Sung H, et al., 2024, Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 74(3): 229–263.
He S, Xia C, Li H, et al., 2024, Cancer Profiles in China and Comparisons with the USA: A Comprehensive Analysis in the Incidence, Mortality, Survival, Staging, and Attribution to Risk Factors. Sci China Life Sci, 67(1): 122–131.
Chinese Society of Interventional Medicine, Clinical Practice Guidelines Committee, 2022, Expert Consensus on Resistance to Transarterial Chemoembolization and Subsequent Treatment of Hepatocellular Carcinoma. Journal of Interventional Radiology, 31(11): 1039–1044.
Reig M, Forner A, Rimola J, et al., 2022, BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update. J Hepatol, 76(3): 681–693.
Ma F, Li F, 2022, Research Progress on Nursing of Patients with Hepatic Cancer Complicated with Embolism Syndrome after TACE Surgery. Continuing Medical Education, 36(05): 149–152.
Yuan C, 2022, Nursing Effects of Clinical Nursing Pathway and Traditional Nursing on Acute Myocardial Infarction. Journal of Integrated Traditional and Western Medicine, 10(35): 34–36 + 30.
Lu Y, Xu F, Shao M, 2025, Research Progress on Cancer Patient Journey Map. Journal of Heze Medical College, 37(03): 90–93.
Shi W, Ye Y, Wu Y, et al., 2026, A Study on the Patient Journey Map of Inpatients with Mood Disorders. BMC Psychiatry, 26: 342.
Yuan P, Zhang Y, Zhang X, et al., 2025, Research Progress on Chronic Disease Patients’ Journey Maps. Nursing Research, 39(16): 2814–2818.
Zhang J, Wang J, Huang C, et al., 2025, Drawing the Journey Map for the Whole Cycle Management of Central Venous Catheter in Liver Cancer Patients and Nursing Countermeasures. Chinese Journal of Nursing, 60(S1): 48–54.
Wang M, 2024, Current Situation and Influencing Factors Analysis of Self-Management Behaviors of Patients with Primary Liver Cancer after TACE Surgery, thesis, Shandong University.
Ji B, Qiu Y, Xia F, et al., 2022, Research on the Impact of Diagnosis Disclosure/Concealment on the Quality of Life of Early and Mid-stage Liver Cancer Patients. Chinese Journal of Medical Ethics, 35(10): 1060–1067.
Huang Y, Zhu L, 2025, Application Status of Patient Journey Maps in the Field of Nursing. Nursing Research, 39(10): 1756–1760.
Yao H, Yuan H, Huang C, et al., 2023, Construction and Application of the Whole-Cycle Management System for Insulin Pump by Diabetes Specialist Nurses. Chinese Journal of Nursing, 58(10): 1166–1171.
Xu G, Pang X, Chen L, et al., 2025, Application Research of the Whole-Cycle Management Model Based on Multidisciplinary Collaboration in the Quality of Intestinal Preparation for Elderly Patients. Chinese Medicine Science, 15(18): 79–82 + 92.
Jing Y, Chen X, Zhang H, 2026, The Impact of the Whole-Cycle Management Model on the Use Effect of PICC in AIDS Patients with Malignant Tumors. Medical Clinical Research, 43(01): 126–129.
Sun H, Zhu Q, He Z, et al., 2025, Application of Peer Support Based on WeChat Groups and Patient Friendship Exchange Meetings in the Self-Management Ability of Patients Undergoing Esophagogastric Variceal Dissection for Liver Cirrhosis. Contemporary Chinese Medicine, 32(6): 169–173.